Envista Holdings Corp cash flow statement
In fiscal 2025, Envista Holdings Corp's operations generated $276m of cash; it spent $45.3m on capital projects, leaving free cash flow of $230m. It returned $167m through buybacks.
Cash flow statement
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 359 | 400 | 398 | 284 | 362 | 183 | 276 | 337 | 276 | 303 |
| Depreciation and amortisation | 121 | 130 | 120 | 122 | 118 | 138 | 136 | 123 | 116 | 115 |
| Stock-based pay | 12 | 13 | 18 | 23 | 28 | 31 | 31 | 35 | 38 | 41 |
| Capital spending | 49 | 72 | 78 | 48 | 55 | 76 | 58 | 34 | 45 | 55 |
| Free cash flow | 310 | 328 | 320 | 236 | 307 | 107 | 218 | 303 | 230 | 248 |
| Free cash flow after stock pay | 298 | 315 | 301 | 214 | 279 | 77 | 187 | 267 | 193 | 208 |
| Share buybacks | — | — | — | — | — | — | 0 | 0 | 167 | 169 |
| Shares issued | 0 | 0 | 643 | 0 | 0 | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Apr 2026 | 2026 Q2Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 71 | 132 | 0 | 89 | 79 | 108 | −3 | 119 |
| Depreciation and amortisation | 29 | 28 | 28 | 30 | 29 | 29 | 29 | 28 |
| Stock-based pay | 10 | 9 | 7 | 10 | 10 | 10 | 10 | 10 |
| Capital spending | 7 | 9 | 6 | 12 | 11 | 16 | 13 | 15 |
| Free cash flow | 63 | 124 | −6 | 76 | 68 | 92 | −16 | 104 |
| Free cash flow after stock pay | 54 | 115 | −13 | 66 | 58 | 81 | −26 | 95 |
Compare with peers
- West Pharmaceutical Services cash flow
- Dentsply Sirona Inc. cash flow
- ICU Medical Inc cash flow
- Align Technology cash flow
- The Cooper Companies cash flow
Head to head: NVST vs WSTNVST vs XRAYICUI vs NVST
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies